Last edition
News about "Han Li Kang"
Fosun Pharma Announces 2026 Interim Results
Fosun Pharma announces its 2026 interim results, highlighting accelerating globalisation and value realisation from its innovative drug portfolio.
Han Li Kang | 27/08/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members